Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 27 Results

Title
Intervention Indication Therapeutic Area Year Actions
Benralizumab for Chronic Obstructive Pulmonary Disease (COPD) Benralizumab (Fasenra; MEDI563) Chronic obstructive pulmonary disease (COPD) Respiratory System 2017 View  |  Download
Beraprost modified release in addition to treprostinil for pulmonary arterial hypertension Esuberaprost (Beraprost-314d; BPS-314d-MR) , Treprostinil (Tyvaso; LIQ861; Orenitram; UT-15C; Remodulin; treprostinil sodium) Pulmonary arterial hypertension (PAH) Cardiovascular System , Respiratory System 2018 View  |  Download
Cysteamine bitartrate for cystic fibrosis exacerbations Cysteamine bitartrate (Procysbi; RP103; Lynovex; NM001; Cystadrops; Mercaptamine) Cystic fibrosis Genetic Disorders , Respiratory System 2018 View  |  Download
Dupilumab in addition to controller medications for children aged 6 to 11 years with asthma controller medications , Dupilumab (Dupixent; REGN-668; SAR-231893; REGN668; SAR231893) Asthma Respiratory System 2021 View  |  Download
Elexacaftor/tezacaftor/ivacaftor (fixed-dose combination) for cystic fibrosis heterozygous for F508del mutation and one minimal function mutation in patients aged 6 to 11 years Elexacaftor (VX-445) , Ivacaftor (Kalydeco; VX-770) , Symkevi (fixed dose combination: Tezacaftor; Ivacaftor) Cystic fibrosis Genetic Disorders , Respiratory System 2019 View  |  Download
Elexacaftor/tezacaftor/ivacaftor (fixed-dose combination) for cystic fibrosis heterozygous for F508del mutation in patients aged 12 years old and older Elexacaftor (VX-445) , Ivacaftor (Kalydeco; VX-770) , Tezacaftor (VX-661) Cystic fibrosis Genetic Disorders , Respiratory System 2020 View  |  Download
Elexacaftor/tezacaftor/ivacaftor (fixed-dose combination) for cystic fibrosis homozygous for F508del mutation in patients aged 6 to 11 years old Elexacaftor (VX-445) , Ivacaftor (Kalydeco; VX-770) , Symkevi (fixed dose combination: Tezacaftor; Ivacaftor) Cystic fibrosis Genetic Disorders , Respiratory System 2019 View  |  Download
Fevipiprant maintenance therapy for uncontrolled asthma – add on therapy Fevipiprant (QAW-039) Asthma Respiratory System 2019 View  |  Download
Gefapixant for chronic refractory cough – First line Gefapixant (MK-7264) Idiopathic chronic cough Respiratory System 2020 View  |  Download
Lenabasum for Diffuse Cutaneous Systemic Sclerosis Lenabasum (JBT-101) Systemic sclerosis Dermatology , Respiratory System 2018 View  |  Download
1 2 3
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications